James V. Caruso
2022
In 2022, James V. Caruso earned a total compensation of $1.5M as President and Chief Executive Officer at Cellectar Biosciences, a 32% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $277,225 |
---|---|
Option Awards | $616,697 |
Salary | $569,250 |
Total | $1,463,172 |
Caruso received $616.7K in option awards, accounting for 42% of the total pay in 2022.
Caruso also received $277.2K in non-equity incentive plan and $569.3K in salary.
Rankings
In 2022, James V. Caruso's compensation ranked 2,269th out of 5,736 executives tracked by ExecPay. In other words, Caruso earned more than 60.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,269 | 60th |
Manufacturing | 1,232 | 61st |
Chemicals And Allied Products | 545 | 62nd |
Drugs | 500 | 62nd |
Pharmaceutical Preparations | 364 | 62nd |
Caruso's colleagues
We found two more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2022.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019